- Bristol Myers’ pivotal year; Should AI be swinging bigger?; and moreWelcome back to Endpoints Weekly! The last week of April brought a downpour of news as several pharma companies reported their first-quarter earnings. Max Gelman took a close look at a make-or-brea…Endpoints · 2mo ago↗ source
- Arvinas’ ‘Protac’ breast cancer drug cleared by FDA<figure><div><img src="https://imgproxy.divecdn.com/xFVDAUb89QQFVPrJL8faaWdXxcY16WqAOJqd9TV5Hi0/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzY5MDAzNjAwLmpwZ…BioPharma Dive · 2mo ago↗ source
- Moderna in talks with FDA over Phase 4 Covid vaccine dataModerna said it's working with US regulators to provide post-marketing data on its Covid-19 vaccines that could restore their use to a wider group after FDA leaders narrowed the label for the produ…